id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
zsBR5tuKEemA3q_8w25VIA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,primary liver cancers,yICC accounts for 10–15% of all , worldwide and is the second mos,TextQuoteSelector,TextPositionSelector,8556,8577,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:41:22.782251+00:00
zQ1B5NuSEemksmsihBPVZg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,platelet derived growth factor,"tocyte growth factor, BRAF, and ", hopefully will lead to effectiv,TextQuoteSelector,TextPositionSelector,36461,36491,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:38:36.162733+00:00
zIh1qtuREemUq-9IVRZRGg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,NASH,o nonalcoholic steatohepatitis (,"), eventual cirrhosis, and HCC [",TextQuoteSelector,TextPositionSelector,13495,13499,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:31:25.646350+00:00
yywoutuLEemXHusV81md0w,b53nbDmi,https://europepmc.org/articles/PMC4452330/,acute cholangitis,ed that biliary obstruction and , may also cause an increase in C,TextQuoteSelector,TextPositionSelector,17889,17906,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:48:26.525402+00:00
yKX2lNuKEemRxBfpOj1KTA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,chronic liver disease,ormal liver and with underlying , [3].Go to:2. EpidemiologyICC ac,TextQuoteSelector,TextPositionSelector,8478,8499,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:41:12.718992+00:00
xjzOntuREemRCNP76mZVdw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,metabolic syndrome, is associated with obesity and ,", is an increasing concern world",TextQuoteSelector,TextPositionSelector,13355,13373,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:31:15.002939+00:00
xdXt_tuSEemXEJ86OFHmbQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,map kinase,in cholangiocarcinoma including ," pathway, hepatocyte growth fact",TextQuoteSelector,TextPositionSelector,36405,36415,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:38:23.954200+00:00
w96h3NuLEemxL7fYCkjqVA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,alpha-fetoprotein,"Carcinoembryonic antigen (CEA), "," (AFP), and carbohydrate antigen",TextQuoteSelector,TextPositionSelector,17232,17249,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:48:14.143482+00:00
vlZqfNuSEem4Wbe_Xj9wjQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,EGF,"s, and epidermal growth factor (",") pathway, involved in cell prol",TextQuoteSelector,TextPositionSelector,35900,35903,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:38:11.380268+00:00
vj6J9NuLEemmhYdpSoC_ow,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Carcinoembryonic antigen, should be assessed (Figure 1). ," (CEA), alpha-fetoprotein (AFP),",TextQuoteSelector,TextPositionSelector,17200,17224,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:48:04.763283+00:00
vizFutuREemdFkPrLS_Pdg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,HCV infection, risk for ICC in the setting of , (hazard ratio (HR): 2.55; 95% c,TextQuoteSelector,TextPositionSelector,12812,12825,"WT_OG,DS",no,[WT_OG][DS],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:31:01.393342+00:00
v8onytuKEemarg9ZKfP8uQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,mouse, epithelium. Recent research in , models suggests the possibility,TextQuoteSelector,TextPositionSelector,7856,7861,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:40:57.959337+00:00
uK2TAtuSEem1NBd0yxSnHw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,epidermal growth factor,", involved in angiogenesis, and "," (EGF) pathway, involved in cell",TextQuoteSelector,TextPositionSelector,35875,35898,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:38:01.823964+00:00
tRVMatuKEemQtJOVh8bc_w,b53nbDmi,https://europepmc.org/articles/PMC4452330/,gastrointestinal cancers,0 years and comprises 3% of all ,. Cholangiocarcinoma can be clas,TextQuoteSelector,TextPositionSelector,7313,7337,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:40:39.918332+00:00
t32hTtuREemjny_NBo4ADA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,hepatitis C virus infection,by Shaib et al. that noted that , was significantly more prevalen,TextQuoteSelector,TextPositionSelector,12597,12624,"WT_OG,DS",no,[WT_OG][DS],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:30:50.458512+00:00
sUmO4NuSEem-T1uIMbfZ_w,b53nbDmi,https://europepmc.org/articles/PMC4452330/,vascular endothelial growth factor,langiocarcinoma. Targets of the ," (VEGF) pathway, involved in ang",TextQuoteSelector,TextPositionSelector,35794,35828,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:37:49.466654+00:00
s9aAytuLEemmhHeC17kvEg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,primary tumor,rch to rule out an extrahepatic , should therefore usually be per,TextQuoteSelector,TextPositionSelector,16804,16817,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:47:47.162303+00:00
rZymJtuLEem7c2uNMp4gDw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,CEA,"-2, TTF-1, ER, PR, BRST-2, AFP, ",", CA19-9, and PSA, may help to e",TextQuoteSelector,TextPositionSelector,16256,16259,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:47:36.724651+00:00
r0i9stuKEemc5eOzs5o70A,b53nbDmi,https://europepmc.org/articles/PMC4452330/,malignancy,helium. While being an uncommon , with an annual incidence in the,TextQuoteSelector,TextPositionSelector,7156,7166,WT_DS,yes,[WT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:40:30.252189+00:00
qipVmNuKEem_Ikex2R7ppw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,malignant transformation,he bile ducts which arises from , of bile duct epithelium. While ,TextQuoteSelector,TextPositionSelector,7082,7106,WT_DS,yes,[WT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:40:21.664538+00:00
qXynptuSEematmeoJNDm0Q,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Biliary Cancer," and ECC. In 2010, the Advanced ",- (ABC-) 02 trial was published.,TextQuoteSelector,TextPositionSelector,33859,33873,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:37:36.381511+00:00
qI-sVNuREemHgr_3hnbIag,b53nbDmi,https://europepmc.org/articles/PMC4452330/,HIV,aceptives Hepatitis C Isoniazid , Asbestos RadonOpen in a separat,TextQuoteSelector,TextPositionSelector,12302,12305,MIS_OG,no,MIS_OG,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:30:25.303389+00:00
pt_dpNuUEemks0vY-XRwEg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,nodal,studies have noted that overall ," status (N0 versus N1), as well ",TextQuoteSelector,TextPositionSelector,29136,29141,WT_GP,yes,[WT_GP][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:51:51.090797+00:00
pNJBFNuKEemSXq9MHup-tA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,cancer of the bile ducts,inoma is a highly fatal primary , which arises from malignant tra,TextQuoteSelector,TextPositionSelector,7039,7063,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:40:12.693096+00:00
p-rsTNuLEemsQ3t_FGzDdg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,AFP,", CDX-2, TTF-1, ER, PR, BRST-2, ",", CEA, CA19-9, and PSA, may help",TextQuoteSelector,TextPositionSelector,16251,16254,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:47:27.387476+00:00
owB5zNuLEemTiXtQGOF4mQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,TTF-1,"rs, including CK7, CK20, CDX-2, ",", ER, PR, BRST-2, AFP, CEA, CA19",TextQuoteSelector,TextPositionSelector,16228,16233,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:47:18.987700+00:00
oquNituREemW9jMzLoHVaQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Hepatitis C,Hepatitis B Oral contraceptives , Isoniazid HIV Asbestos RadonOpe,TextQuoteSelector,TextPositionSelector,12280,12291,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:30:15.545152+00:00
oDZQeNuKEemVRxt8WJHgyQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Cholangiocarcinoma,r articles in PMC.Go to:Abstract, is a highly fatal primary cance,TextQuoteSelector,TextPositionSelector,6994,7012,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:40:04.951732+00:00
niyeytuREemsFjvuHNyyiQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Hepatitis B,otrastViral risk factors Dioxin , Oral contraceptives Hepatitis C,TextQuoteSelector,TextPositionSelector,12248,12259,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:30:07.935685+00:00
nLVqqtuQEemXIit8jwjWfw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Cancer,y from Memorial Sloan Kettering , Center noted that only 30% of p,TextQuoteSelector,TextPositionSelector,27383,27389,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:22:56.029609+00:00
mzYFrNuSEem0WVumuCRVCA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,solitary tumors, of recurrence in patients with , without lymph node metastases w,TextQuoteSelector,TextPositionSelector,31300,31315,WS_DS,yes,[WS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:37:12.417941+00:00
mc1SqNuLEemW8Mutc4Jhtg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,CK20,"hemical markers, including CK7, ",", CDX-2, TTF-1, ER, PR, BRST-2, ",TextQuoteSelector,TextPositionSelector,16215,16219,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:47:03.687395+00:00
mTaEituREemK6V9rx37RBg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Biliary papillomatosis,le duct adenomas Vinyl chloride , ThorotrastViral risk factors Di,TextQuoteSelector,TextPositionSelector,12189,12211,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:29:59.587125+00:00
mFCaXNuQEem-TLsPHvPWFQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,cancer,ith localized disease underwent , directed surgery [54]. While th,TextQuoteSelector,TextPositionSelector,26713,26719,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:22:48.425854+00:00
mCJR6NuUEemuhDt8_56uZA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Tumor, or without vascular invasionT3 , perforating the visceral perito,TextQuoteSelector,TextPositionSelector,24306,24311,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:51:26.250469+00:00
lM7wQNuLEemRxyuSFWJFsQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,CK7,"istochemical markers, including ",", CK20, CDX-2, TTF-1, ER, PR, BR",TextQuoteSelector,TextPositionSelector,16210,16213,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:46:55.245235+00:00
k82LENuREem3weMT9RvXtw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Bile duct adenomas,l hepatic fibrosis Nitrosamines , Vinyl chloride Biliary papillom,TextQuoteSelector,TextPositionSelector,12155,12173,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:29:50.615062+00:00
k1ag5NuSEembQ2sCfWCoUw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,lymph node metastasis,o underwent lymphadenectomy had ," [58]. Some investigators, howev",TextQuoteSelector,TextPositionSelector,28480,28501,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:36:59.226588+00:00
jkTyxNuLEemsKMveWajnCw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,tumor, to elucidate the origin of the ,. Some immunohistochemical marke,TextQuoteSelector,TextPositionSelector,16159,16164,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:46:44.115095+00:00
jW9oKNuSEemc7ftZnXXPpg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,metastatic nodal disease,"f these, 32% were found to have ", [50]. A second meta-analysis fr,TextQuoteSelector,TextPositionSelector,28265,28289,"WT_GP,DS",no,[WT_GP][DS],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:36:49.436369+00:00
i-fQNtuREemSY3PDj7AdAw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Congenital hepatic fibrosis,chal cystsChemical risk factors , Nitrosamines Bile duct adenomas,TextQuoteSelector,TextPositionSelector,12114,12141,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:29:37.356740+00:00
hVu6lNuLEemOvFsgswMe6w,b53nbDmi,https://europepmc.org/articles/PMC4452330/,adenocarcinomas,oma.” Due to the fact that most , of the liver are metastatic in ,TextQuoteSelector,TextPositionSelector,15993,16008,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:46:29.400344+00:00
gsNbftuREem56Q94grRynQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Choledochal cysts,"sease 
Opisthorchis viverrini 
 ",Chemical risk factors Congenital,TextQuoteSelector,TextPositionSelector,12075,12092,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:29:21.921949+00:00
gr2mvNuQEemc6t9PXZuGFA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Intrahepatic Cholangiocarcinoma,ciplinary Care of Patients with ,: Updates in ManagementKelly J. ,TextQuoteSelector,TextPositionSelector,5197,5228,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:22:12.364034+00:00
gpEhVtuUEemmjocODJ5FTg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,extrahepatic primary tumor,t [36]. A search to rule out an , should therefore usually be per,TextQuoteSelector,TextPositionSelector,16791,16817,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:50:50.096788+00:00
gfGeANuLEemCGad5uZvQ6A,b53nbDmi,https://europepmc.org/articles/PMC4452330/,adenocarcinoma,subsequent pathology revealing “,.” Due to the fact that most ade,TextQuoteSelector,TextPositionSelector,15950,15964,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:46:23.605647+00:00
fDsyXtuREemOwF-fAeZh_Q,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Caroli's disease," factors 
Clonorchis sinensis 
 "," 
Opisthorchis viverrini 
 Chole",TextQuoteSelector,TextPositionSelector,12032,12048,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:29:11.082145+00:00
e7XehNuLEem7csdoBFez3Q,b53nbDmi,https://europepmc.org/articles/PMC4452330/,metastatic disease,om hepatocellular carcinoma and ,. While there is a theoretical r,TextQuoteSelector,TextPositionSelector,15599,15617,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:46:13.119197+00:00
dnqLWNuREemmhi9VsU_LFQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Opisthorchis viverrini,"is sinensis 
 Caroli's disease 
"," 
 Choledochal cystsChemical ris",TextQuoteSelector,TextPositionSelector,12050,12072,MIS_OG,no,MIS_OG,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:29:01.399614+00:00
daF6JNuSEemfxJt6O5wSnA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Multiple tumors,tumor with vascular invasionT2b ,", with or without vascular invas",TextQuoteSelector,TextPositionSelector,24253,24268,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:36:09.396243+00:00
dZPP0NuUEem3xrOwyP1Qig,b53nbDmi,https://europepmc.org/articles/PMC4452330/,intraductal tumor,ary tumorTis Carcinoma in situ (,)T1 Solitary tumor without vascu,TextQuoteSelector,TextPositionSelector,24147,24164,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:50:28.399428+00:00
cm8RENuLEemxLjfpwaT1-A,b53nbDmi,https://europepmc.org/articles/PMC4452330/,cholangiocarcinomas,ration (EUS-FNA) to distinguish , from hepatocellular carcinoma a,TextQuoteSelector,TextPositionSelector,15545,15564,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:45:57.579037+00:00
cDRv8tuREem-Sj-gaI2Tvg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Clonorchis sinensis,"factorsCongenital risk factors 
"," 
 Caroli's disease 
Opisthorchi",TextQuoteSelector,TextPositionSelector,12010,12029,MIS_OG,no,MIS_OG,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:28:50.749771+00:00
bl9KjtuSEemsTcemLOamBg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Solitary tumor,a in situ (intraductal tumor)T1 , without vascular invasionT2a So,TextQuoteSelector,TextPositionSelector,24168,24182,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:35:57.187901+00:00
aMxamtuREemtPqtfchD3KQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,NAFLD,nalcoholic fatty liver disease (,) and hepatitis C. The associati,TextQuoteSelector,TextPositionSelector,12443,12448,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:28:38.379092+00:00
aHfK-NuLEem_FM_t2XGoiQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,jaundice,"bdominal pain, night sweats, or ","; however, the frequent biliary ",TextQuoteSelector,TextPositionSelector,15262,15270,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:45:40.862817+00:00
_ltwltuREem_LT-SHeUmQg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,PSA,", BRST-2, AFP, CEA, CA19-9, and ",", may help to exclude common pri",TextQuoteSelector,TextPositionSelector,16273,16276,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:32:49.379321+00:00
_g2ZQNuPEemeRT8DqWIqfQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,malignancies,geneous nature of biliary tract ,". Historically, 5-FU was the fir",TextQuoteSelector,TextPositionSelector,33046,33058,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:18:29.868352+00:00
ZFkMONuMEem1LI_wXmi9Hw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,localized disease, that only 37% of patients with , underwent cancer directed surge,TextQuoteSelector,TextPositionSelector,26685,26702,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:52:43.509858+00:00
Z4iLbNuSEemQuoMFQK3meQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Carcinoma in situ,No evidence of primary tumorTis , (intraductal tumor)T1 Solitary ,TextQuoteSelector,TextPositionSelector,24128,24145,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:35:45.779217+00:00
YxDonNuLEem7cRujEy_ahA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,failure to thrive,"tomegaly, malaise, weight loss, ",", abdominal pain, night sweats, ",TextQuoteSelector,TextPositionSelector,15210,15227,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:45:31.661839+00:00
YLpxntuQEemHgQP_M119kA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,resp,"nly (47% versus 20% versus 33%, ",".; P = 0.03) [119]. However, thi",TextQuoteSelector,TextPositionSelector,43757,43761,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:21:15.418301+00:00
XgWxoNuSEem7-xttkCnu8g,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Primary tumor,"Duct Tumors (7th edition, 2010).", (T)TX Primary tumor cannot be a,TextQuoteSelector,TextPositionSelector,24041,24054,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:35:29.788256+00:00
XDV8QNuLEemRxdtscyYj0A,b53nbDmi,https://europepmc.org/articles/PMC4452330/,HBV,he major risk factors including ,", HCV, PSC, NASH, or alcohol ind",TextQuoteSelector,TextPositionSelector,14748,14751,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:45:20.267202+00:00
WtkittuQEem9k69T5oR1Fw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,hilar cholangiocarcinoma, transplant for intrahepatic or ,. The 5-year tumor recurrence-fr,TextQuoteSelector,TextPositionSelector,43407,43431,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:21:05.520221+00:00
WOnAfNuREembQJP4aPfRlQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Inflammatory bowel disease,iary cirrhosis Type II diabetes , Excessive alcohol intake Biliar,TextQuoteSelector,TextPositionSelector,11878,11904,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:28:11.731816+00:00
W8cJituMEemmho_oqaxdCQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,liver metastases,neal carcinomatosis (11/14) and , (5/14) in a small subset of pat,TextQuoteSelector,TextPositionSelector,26059,26075,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:52:29.044577+00:00
VZlfQNuMEemjnktzVjAEJQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,peritoneal carcinomatosis, staging laparoscopy identified , (11/14) and liver metastases (5,TextQuoteSelector,TextPositionSelector,26021,26046,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:52:18.759720+00:00
VCS-MNuQEemavc-o9WQEtg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,early necrosis,nical effectiveness measured by , was seen in 90–100% of small tu,TextQuoteSelector,TextPositionSelector,42594,42608,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:20:54.289253+00:00
VCJs3tuLEemOuwdJnrUNPw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,nonalcoholic steatohepatitis,nited States. NAFLD can lead to ," (NASH), eventual cirrhosis, and",TextQuoteSelector,TextPositionSelector,13465,13493,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:45:06.653763+00:00
TzlwvNuSEemvA68yXS0Q7Q,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Intrahepatic Bile Duct Tumors, Cancer (AJCC). TNM Staging for ," (7th edition, 2010).Primary tum",TextQuoteSelector,TextPositionSelector,23991,24020,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:35:05.014412+00:00
TVidyNuREemQuW-bOJD_ig,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Type II diabetes,sis  Age > 65 Biliary cirrhosis , Inflammatory bowel disease Exce,TextQuoteSelector,TextPositionSelector,11861,11877,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:27:52.409504+00:00
TUqbotuQEemksTuWYJx64A,b53nbDmi,https://europepmc.org/articles/PMC4452330/,solid tumors,response evaluation criteria in ," (mRECIST), intra-arterial thera",TextQuoteSelector,TextPositionSelector,41765,41777,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:20:42.795052+00:00
RmdlJtuREemK6F9V48FGSQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Biliary cirrhosis,o use Hepatolithiasis  Age > 65 , Type II diabetes Inflammatory b,TextQuoteSelector,TextPositionSelector,11843,11860,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:27:40.683587+00:00
Rl-LgNuMEemk75-wv0C3ww,b53nbDmi,https://europepmc.org/articles/PMC4452330/,abdominal tumors,"cations, similar to other solid ",", are included with N1 disease c",TextQuoteSelector,TextPositionSelector,23714,23730,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:51:53.239162+00:00
Qzem5tuLEemeQ0NBCmNRdA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,HCV,) [23]. The association between , and ICC is not unique to the US,TextQuoteSelector,TextPositionSelector,12928,12931,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:44:38.328117+00:00
QRcQWNuREemtPV-Fm8R77Q,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Hepatolithiasis,erosing cholangitis Tobacco use ,  Age > 65 Biliary cirrhosis Typ,TextQuoteSelector,TextPositionSelector,11817,11832,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:27:31.749329+00:00
Q63cxtuQEem2kU-dVGHddA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,BRAF,"hway, hepatocyte growth factor, ",", and platelet derived growth fa",TextQuoteSelector,TextPositionSelector,36451,36455,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:20:26.588373+00:00
PsdJpNuQEemRy_Oan-H-tg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,hepatocyte growth factor,"a including map kinase pathway, ",", BRAF, and platelet derived gro",TextQuoteSelector,TextPositionSelector,36425,36449,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:20:18.371639+00:00
PWhNUNuMEemtONdA_ZKajg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,T4,"nvasion of adjacent organs, and ",: tumors with any periductal-inf,TextQuoteSelector,TextPositionSelector,23590,23592,WT_OG,yes,[WT_OG][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:51:38.071142+00:00
PQC56NuLEemo1h9xhlu3qg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,hepatitis C,fatty liver disease (NAFLD) and ,. The association between ICC an,TextQuoteSelector,TextPositionSelector,12454,12465,"WT_OG,DS",yes,[WT_OG][DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:44:27.973258+00:00
NbG-1NuMEemXH2MOpuplCw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,tumors,ation is based on the number of ,", vascular invasion, and direct ",TextQuoteSelector,TextPositionSelector,23238,23244,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:51:25.247712+00:00
M6804NuREemb3V-lMG1Xqw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Primary sclerosing cholangitis,flammatory risk factors Obesity , Tobacco use Hepatolithiasis  Ag,TextQuoteSelector,TextPositionSelector,11774,11804,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:27:09.342676+00:00
M1k91NuLEem_I9PhCpRBaQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,nonalcoholic fatty liver disease,ased in incidence worldwide are , (NAFLD) and hepatitis C. The as,TextQuoteSelector,TextPositionSelector,12409,12441,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:44:11.722317+00:00
LtxhCNuSEemawsP9AgYSYA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,regional lymph node metastasis,"umors, symptomatic disease, and ", all to be associated with a wor,TextQuoteSelector,TextPositionSelector,20941,20971,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:34:10.759272+00:00
LMwjfNuMEem3u2Or-wDfJQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,multiple tumors," presence of vascular invasion, ",", symptomatic disease, and regio",TextQuoteSelector,TextPositionSelector,20899,20914,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:51:10.306970+00:00
LAGhcNuQEemK5-N_kjfQkA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,VEGF,ular endothelial growth factor (,") pathway, involved in angiogene",TextQuoteSelector,TextPositionSelector,35830,35834,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:19:46.889484+00:00
KhfhgNuLEemtNzt652vQzw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,tobacco,"s B infection [15, 17, 18], and ", use [14] have been implicated i,TextQuoteSelector,TextPositionSelector,11074,11081,WT_OG,no,[WT_OG],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:43:56.204591+00:00
Ja2xMtuREemvLgM_z7XiNg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Obesity,actorsInflammatory risk factors , Primary sclerosing cholangitis ,TextQuoteSelector,TextPositionSelector,11766,11773,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:26:45.823513+00:00
JGFuZNuQEembDmOVNIO7JQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,oncogenesis,isms and mutations critical for , in cholangiocarcinoma. Targets ,TextQuoteSelector,TextPositionSelector,35744,35755,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:19:34.178860+00:00
J012ZtuSEemSZpeO-waflw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,intrahepatic cholangiocarcinoma,Figure 1Treatment algorithm for ,.4.1. ICC on Cross-Sectional Ima,TextQuoteSelector,TextPositionSelector,18286,18317,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:33:58.056688+00:00
IkvtDNuLEemHe9NZ-BdjiQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,cirrhosis,"besity [15], diabetes [14, 16], ",", hepatitis B infection [15, 17,",TextQuoteSelector,TextPositionSelector,11023,11032,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:43:43.196093+00:00
HyPyaNuMEemeROPi9Ihauw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Cancer,CC)/International Union Against , (UICC) guidelines that were pub,TextQuoteSelector,TextPositionSelector,20440,20446,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:50:47.346424+00:00
HiFyeNuREem56J8Gt86btQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,hepatitis B infection,", diabetes [14, 16], cirrhosis, "," [15, 17, 18], and tobacco use [",TextQuoteSelector,TextPositionSelector,11034,11055,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:26:33.104974+00:00
HfKuxtuLEembPuvqaEBWwQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,diabetes,"ver disease [14], obesity [15], "," [14, 16], cirrhosis, hepatitis ",TextQuoteSelector,TextPositionSelector,11004,11012,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:43:35.778508+00:00
H8kEHtuSEemP9udPBRQ2Dg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,CYFRA21-1,re specific serum marks such as ,", claudin-4, insulin-like growth",TextQuoteSelector,TextPositionSelector,18069,18078,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:33:45.347561+00:00
GJK_etuLEemsQSshPX856A,b53nbDmi,https://europepmc.org/articles/PMC4452330/,obesity,"s alcoholic liver disease [14], "," [15], diabetes [14, 16], cirrho",TextQuoteSelector,TextPositionSelector,10990,10997,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:43:26.852961+00:00
GE2aOtuQEemk9J8p6ku0-w,b53nbDmi,https://europepmc.org/articles/PMC4452330/,rare diseases,ing quality phase III trials in , such as cholangiocarcinoma. The,TextQuoteSelector,TextPositionSelector,35098,35111,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:19:13.943699+00:00
G6osONuMEemjnVuUOlwCRw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Cancer,the American Joint Committee on , (AJCC)/International Union Agai,TextQuoteSelector,TextPositionSelector,20398,20404,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:50:41.545780+00:00
FfYpDtuREemA4NtsCLhxHw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,HCC,s for hepatocellular carcinoma (,) such as alcoholic liver diseas,TextQuoteSelector,TextPositionSelector,10947,10950,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:26:19.395990+00:00
F8TisNuSEemsSxO695UP7Q,b53nbDmi,https://europepmc.org/articles/PMC4452330/,biliary obstruction," However, it must be noted that ", and acute cholangitis may also ,TextQuoteSelector,TextPositionSelector,17865,17884,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:33:31.986171+00:00
F7ycztuQEemk89d4_-aRWw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,bile duct cancers,ile this study did not stratify ," by location, upon subgroup anal",TextQuoteSelector,TextPositionSelector,34649,34666,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:19:12.933190+00:00
EsF7BNuLEemSX8cGTS6hfQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,alcoholic liver disease,ellular carcinoma (HCC) such as ," [14], obesity [15], diabetes [1",TextQuoteSelector,TextPositionSelector,10960,10983,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:43:17.092297+00:00
DwiOUtuREemmiuuU_sl0bA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,parasitic biliary infection,"sts, primary biliary cirrhosis, ", with Clonorchis sinensis or Opi,TextQuoteSelector,TextPositionSelector,10615,10642,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:26:07.762215+00:00
DX1tGNuSEemtqJ_SUUtXxw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,extrahepatic adenocarcinomas,tatic lesions to the liver from , of the foregut [36]. A search t,TextQuoteSelector,TextPositionSelector,16717,16745,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:33:14.725614+00:00
CnqNeNuLEembCsN-C6FZPg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,chronic pancreatitis,"inflammatory bowel disease, and "," [14], as well as the historical",TextQuoteSelector,TextPositionSelector,10727,10747,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:43:03.222861+00:00
CVfjFNuQEemefLPCjTsGog,b53nbDmi,https://europepmc.org/articles/PMC4452330/,biliary tract cancer,trial in patients with advanced , that compared single agent gemc,TextQuoteSelector,TextPositionSelector,33987,34007,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:18:48.815809+00:00
CQonrtuMEemu_4Mb9ak0cA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,metastatic adenocarcinoma,"liably distinguish between ICC, ", from extrahepatic primaries or ,TextQuoteSelector,TextPositionSelector,20232,20257,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:50:10.212003+00:00
BgynstuQEemW85daiNztTA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,biliary tract cancers,reatic (53 patients) as well as ," (37 patients), 5-FU, leucovorin",TextQuoteSelector,TextPositionSelector,33278,33299,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:18:43.244871+00:00
BdnR3NuSEemo2W-m11Gv3g,b53nbDmi,https://europepmc.org/articles/PMC4452330/,ICCs ,"ung, breast, and prostate [29]. ","are often positive for CK7, CEA,",TextQuoteSelector,TextPositionSelector,16369,16374,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:33:01.915686+00:00
Amu4DtuMEemOve_bl3scGQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,tumors,ministration showed that 74% of , had hyperattenuating delayed co,TextQuoteSelector,TextPositionSelector,20091,20097,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:49:59.216529+00:00
AeGiDtuREemP1UdML0Ojug,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Cholangiocarcinoma,management.Go to:1. Introduction, is a highly fatal primary cance,TextQuoteSelector,TextPositionSelector,7700,7718,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:25:45.692120+00:00
AZfJPNuLEemarz8xHWefxg,b53nbDmi,https://europepmc.org/articles/PMC4452330/,inflammatory bowel disease,"nsis or Opisthorchis viverrini, ",", and chronic pancreatitis [14],",TextQuoteSelector,TextPositionSelector,10695,10721,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:42:48.205245+00:00
9xM6oNuPEemvLb-bonNDyA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,lymph node metastases,ts with solitary tumors without ," was only 47%, while recurrence ",TextQuoteSelector,TextPositionSelector,31324,31345,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:18:18.192576+00:00
9aFWjNuREemIFfccMUCN-g,b53nbDmi,https://europepmc.org/articles/PMC4452330/,BRST-2,"K7, CK20, CDX-2, TTF-1, ER, PR, ",", AFP, CEA, CA19-9, and PSA, may",TextQuoteSelector,TextPositionSelector,16243,16249,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:32:34.678987+00:00
934IJtuKEemK4f8pOieDDA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Clonorchis sinensis,arasitic biliary infection with ," or Opisthorchis viverrini, infl",TextQuoteSelector,TextPositionSelector,10648,10667,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:42:31.291461+00:00
8CoF-tuREemSZUNWgC3IiQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,PR,"ng CK7, CK20, CDX-2, TTF-1, ER, ",", BRST-2, AFP, CEA, CA19-9, and ",TextQuoteSelector,TextPositionSelector,16239,16241,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:32:25.592027+00:00
8C-6VtuKEemsJ8_hIpVItQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,primary biliary cirrhosis,"tolithiasis, choledochal cysts, ",", parasitic biliary infection wi",TextQuoteSelector,TextPositionSelector,10588,10613,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:42:18.887875+00:00
6tg0tNuREematQe_o7doBQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,ER,"luding CK7, CK20, CDX-2, TTF-1, ",", PR, BRST-2, AFP, CEA, CA19-9, ",TextQuoteSelector,TextPositionSelector,16235,16237,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:32:16.654355+00:00
64T2tNuQEemmiVNUtV1rjQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,ICC,e classified into intrahepatic (,) and extrahepatic (including hi,TextQuoteSelector,TextPositionSelector,7395,7398,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:25:08.205292+00:00
6062aNuKEemsE7fFDtmJKA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,choledochal cysts,"g cholangitis, hepatolithiasis, ",", primary biliary cirrhosis, par",TextQuoteSelector,TextPositionSelector,10569,10586,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:42:10.842819+00:00
5qLXSNuKEemQtXND-SAHTQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,hepatolithiasis,"primary sclerosing cholangitis, ",", choledochal cysts, primary bil",TextQuoteSelector,TextPositionSelector,10552,10567,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:42:03.110469+00:00
5Vb2GtuREemRCedH-LOAFA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,CDX-2,"l markers, including CK7, CK20, ",", TTF-1, ER, PR, BRST-2, AFP, CE",TextQuoteSelector,TextPositionSelector,16221,16226,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:32:07.331602+00:00
4RLzttuLEemjnC90bms9Uw,b53nbDmi,https://europepmc.org/articles/PMC4452330/,biglycan,"inding protein 5 (IGFBP-5), and "," exist; however, none of these a",TextQuoteSelector,TextPositionSelector,18151,18159,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:49:03.268944+00:00
4F3nktuKEemP84MSbiX1BA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,primary sclerosing cholangitis,eral other risk factors include ,", hepatolithiasis, choledochal c",TextQuoteSelector,TextPositionSelector,10520,10550,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:41:52.503263+00:00
3PUo1NuREemUrMvs5060LA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,alcohol induced cirrhosis,"cluding HBV, HCV, PSC, NASH, or "," [29]. As such, it is likely tha",TextQuoteSelector,TextPositionSelector,14772,14797,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:31:53.215449+00:00
2wod5tuLEemdEzNWrsF33A,b53nbDmi,https://europepmc.org/articles/PMC4452330/,IGFBP-5,rowth factor binding protein 5 (,"), and biglycan exist; however, ",TextQuoteSelector,TextPositionSelector,18137,18144,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:48:53.057694+00:00
1pY-TtuKEemkrzvODzJfuA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,hepatocellular carcinoma, primary liver malignancy after , with a varying incidence worldw,TextQuoteSelector,TextPositionSelector,8649,8673,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:41:36.173329+00:00
1jzSctuLEemsKZfbDtBxQQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,insulin-like growth factor binding protein 5,"s such as CYFRA21-1, claudin-4, "," (IGFBP-5), and biglycan exist; ",TextQuoteSelector,TextPositionSelector,18091,18135,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:48:45.097726+00:00
1aKVBNuQEem3wM_eEnu05w,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Klatskin Tumors,n of hilar cholangiocarcinomas (,) on the incidence of intra- and,TextQuoteSelector,TextPositionSelector,48203,48218,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:24:31.562981+00:00
1IInqtuSEembEL-yUp5efQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,perihilar cholangiocarcinoma, The role of transplantation in , is significantly more defined; ,TextQuoteSelector,TextPositionSelector,42986,43014,WS_DS,yes,[WS_DS][ALL],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:38:48.564972+00:00
0NNlEtuLEemmg2s1zJoxhA,b53nbDmi,https://europepmc.org/articles/PMC4452330/,claudin-4," serum marks such as CYFRA21-1, ",", insulin-like growth factor bin",TextQuoteSelector,TextPositionSelector,18080,18089,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:48:35.924914+00:00
02kpPNuREemSZL9UNqG2QQ,b53nbDmi,https://europepmc.org/articles/PMC4452330/,PSC,"isk factors including HBV, HCV, ",", NASH, or alcohol induced cirrh",TextQuoteSelector,TextPositionSelector,14758,14761,MIS_DS,no,MIS_DS,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T10:31:37.335908+00:00
-TfEYtuLEem2je8s5YrW7A,b53nbDmi,https://europepmc.org/articles/PMC4452330/,desmoplastic,"ation, a finding related to the ", nature of the tumor. In one stu,TextQuoteSelector,TextPositionSelector,19908,19920,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:49:43.508149+00:00
-3INdNuKEemmgg_of4Pvog,b53nbDmi,https://europepmc.org/articles/PMC4452330/,Opisthorchis viverrini,ion with Clonorchis sinensis or ,", inflammatory bowel disease, an",TextQuoteSelector,TextPositionSelector,10671,10693,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-20T09:42:37.918300+00:00
